Swiss National Bank Sells 400 Shares of Maximus, Inc. (NYSE:MMS)

Swiss National Bank decreased its position in Maximus, Inc. (NYSE:MMS) by 0.3% in the fourth quarter, Holdings Channel.com reports. The firm owned 118,307 shares of the health services provider’s stock after selling 400 shares during the quarter. Swiss National Bank’s holdings in Maximus were worth $8,832,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in MMS. Atria Investments Inc bought a new position in Maximus in the third quarter worth $244,000. Natixis Advisors LLC bought a new position in Maximus in the third quarter worth $955,000. Connor Clark & Lunn Investment Management Ltd. grew its stake in shares of Maximus by 221.9% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 47,963 shares of the health services provider’s stock worth $4,468,000 after acquiring an additional 33,063 shares during the last quarter. Intech Investment Management LLC grew its stake in shares of Maximus by 30.5% in the third quarter. Intech Investment Management LLC now owns 23,832 shares of the health services provider’s stock worth $2,220,000 after acquiring an additional 5,566 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Maximus by 12.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider’s stock worth $86,552,000 after acquiring an additional 102,350 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on MMS shares. Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price on the stock in a research note on Thursday, January 2nd. StockNews.com cut Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th.

Maximus Trading Down 0.1 %

NYSE MMS opened at $67.12 on Friday. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97. The stock has a market cap of $3.80 billion, a P/E ratio of 14.43 and a beta of 0.71. The stock’s fifty day moving average price is $71.07 and its 200-day moving average price is $78.64. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. As a group, equities analysts forecast that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.79%. Maximus’s dividend payout ratio (DPR) is presently 25.81%.

Insider Activity at Maximus

In related news, Director Jan Madsen sold 2,439 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now directly owns 18,097 shares of the company’s stock, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the firm’s stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.